The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostats & Sealants Market Research Report 2025
Synopsis
The global Hemostats & Sealants market was valued at US$ 2801.8 million in 2023 and is anticipated to reach US$ 3442.3 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemostats & Sealants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats & Sealants.
Report Scope
The Hemostats & Sealants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostats & Sealants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostats & Sealants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Baxter
C.R. Bard
Cryolife Inc
Advanced Medical Solutions Group
Pfizer
Stryker
Medtronic PLC
Cohera Medical Inc
B.Braun Melsungen AG
Smith & Nephew PLC
CSL Behring
Integra Lifesciences Corp
Segment by Type
Topical Hemostat
Adhesive and Tissue Sealants
Natural Tissue Sealant
Other
Segment by Application
Hospitals
Clinics
Surgery Centers
Personal Use
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostats & Sealants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostats & Sealants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hemostats & Sealants market was valued at US$ 2801.8 million in 2023 and is anticipated to reach US$ 3442.3 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemostats & Sealants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats & Sealants.
Report Scope
The Hemostats & Sealants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostats & Sealants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostats & Sealants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Baxter
C.R. Bard
Cryolife Inc
Advanced Medical Solutions Group
Pfizer
Stryker
Medtronic PLC
Cohera Medical Inc
B.Braun Melsungen AG
Smith & Nephew PLC
CSL Behring
Integra Lifesciences Corp
Segment by Type
Topical Hemostat
Adhesive and Tissue Sealants
Natural Tissue Sealant
Other
Segment by Application
Hospitals
Clinics
Surgery Centers
Personal Use
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostats & Sealants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostats & Sealants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostats & Sealants Market Overview
1.1 Product Overview and Scope of Hemostats & Sealants
1.2 Hemostats & Sealants Segment by Type
1.2.1 Global Hemostats & Sealants Market Value Comparison by Type (2024-2030)
1.2.2 Topical Hemostat
1.2.3 Adhesive and Tissue Sealants
1.2.4 Natural Tissue Sealant
1.2.5 Other
1.3 Hemostats & Sealants Segment by Application
1.3.1 Global Hemostats & Sealants Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Surgery Centers
1.3.5 Personal Use
1.3.6 Other
1.4 Global Hemostats & Sealants Market Size Estimates and Forecasts
1.4.1 Global Hemostats & Sealants Revenue 2019-2030
1.4.2 Global Hemostats & Sealants Sales 2019-2030
1.4.3 Global Hemostats & Sealants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostats & Sealants Market Competition by Manufacturers
2.1 Global Hemostats & Sealants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostats & Sealants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostats & Sealants Average Price by Manufacturers (2019-2024)
2.4 Global Hemostats & Sealants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostats & Sealants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostats & Sealants, Product Type & Application
2.7 Hemostats & Sealants Market Competitive Situation and Trends
2.7.1 Hemostats & Sealants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostats & Sealants Players Market Share by Revenue
2.7.3 Global Hemostats & Sealants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostats & Sealants Retrospective Market Scenario by Region
3.1 Global Hemostats & Sealants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostats & Sealants Global Hemostats & Sealants Sales by Region: 2019-2030
3.2.1 Global Hemostats & Sealants Sales by Region: 2019-2024
3.2.2 Global Hemostats & Sealants Sales by Region: 2025-2030
3.3 Global Hemostats & Sealants Global Hemostats & Sealants Revenue by Region: 2019-2030
3.3.1 Global Hemostats & Sealants Revenue by Region: 2019-2024
3.3.2 Global Hemostats & Sealants Revenue by Region: 2025-2030
3.4 North America Hemostats & Sealants Market Facts & Figures by Country
3.4.1 North America Hemostats & Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostats & Sealants Sales by Country (2019-2030)
3.4.3 North America Hemostats & Sealants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostats & Sealants Market Facts & Figures by Country
3.5.1 Europe Hemostats & Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostats & Sealants Sales by Country (2019-2030)
3.5.3 Europe Hemostats & Sealants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostats & Sealants Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostats & Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostats & Sealants Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostats & Sealants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostats & Sealants Market Facts & Figures by Country
3.7.1 Latin America Hemostats & Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostats & Sealants Sales by Country (2019-2030)
3.7.3 Latin America Hemostats & Sealants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostats & Sealants Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostats & Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostats & Sealants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostats & Sealants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostats & Sealants Sales by Type (2019-2030)
4.1.1 Global Hemostats & Sealants Sales by Type (2019-2024)
4.1.2 Global Hemostats & Sealants Sales by Type (2025-2030)
4.1.3 Global Hemostats & Sealants Sales Market Share by Type (2019-2030)
4.2 Global Hemostats & Sealants Revenue by Type (2019-2030)
4.2.1 Global Hemostats & Sealants Revenue by Type (2019-2024)
4.2.2 Global Hemostats & Sealants Revenue by Type (2025-2030)
4.2.3 Global Hemostats & Sealants Revenue Market Share by Type (2019-2030)
4.3 Global Hemostats & Sealants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostats & Sealants Sales by Application (2019-2030)
5.1.1 Global Hemostats & Sealants Sales by Application (2019-2024)
5.1.2 Global Hemostats & Sealants Sales by Application (2025-2030)
5.1.3 Global Hemostats & Sealants Sales Market Share by Application (2019-2030)
5.2 Global Hemostats & Sealants Revenue by Application (2019-2030)
5.2.1 Global Hemostats & Sealants Revenue by Application (2019-2024)
5.2.2 Global Hemostats & Sealants Revenue by Application (2025-2030)
5.2.3 Global Hemostats & Sealants Revenue Market Share by Application (2019-2030)
5.3 Global Hemostats & Sealants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostats & Sealants Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Hemostats & Sealants Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C.R. Bard
6.3.1 C.R. Bard Corporation Information
6.3.2 C.R. Bard Description and Business Overview
6.3.3 C.R. Bard Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 C.R. Bard Hemostats & Sealants Product Portfolio
6.3.5 C.R. Bard Recent Developments/Updates
6.4 Cryolife Inc
6.4.1 Cryolife Inc Corporation Information
6.4.2 Cryolife Inc Description and Business Overview
6.4.3 Cryolife Inc Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cryolife Inc Hemostats & Sealants Product Portfolio
6.4.5 Cryolife Inc Recent Developments/Updates
6.5 Advanced Medical Solutions Group
6.5.1 Advanced Medical Solutions Group Corporation Information
6.5.2 Advanced Medical Solutions Group Description and Business Overview
6.5.3 Advanced Medical Solutions Group Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Advanced Medical Solutions Group Hemostats & Sealants Product Portfolio
6.5.5 Advanced Medical Solutions Group Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Hemostats & Sealants Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stryker Hemostats & Sealants Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 Medtronic PLC
6.8.1 Medtronic PLC Corporation Information
6.8.2 Medtronic PLC Description and Business Overview
6.8.3 Medtronic PLC Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtronic PLC Hemostats & Sealants Product Portfolio
6.8.5 Medtronic PLC Recent Developments/Updates
6.9 Cohera Medical Inc
6.9.1 Cohera Medical Inc Corporation Information
6.9.2 Cohera Medical Inc Description and Business Overview
6.9.3 Cohera Medical Inc Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cohera Medical Inc Hemostats & Sealants Product Portfolio
6.9.5 Cohera Medical Inc Recent Developments/Updates
6.10 B.Braun Melsungen AG
6.10.1 B.Braun Melsungen AG Corporation Information
6.10.2 B.Braun Melsungen AG Description and Business Overview
6.10.3 B.Braun Melsungen AG Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 B.Braun Melsungen AG Hemostats & Sealants Product Portfolio
6.10.5 B.Braun Melsungen AG Recent Developments/Updates
6.11 Smith & Nephew PLC
6.11.1 Smith & Nephew PLC Corporation Information
6.11.2 Smith & Nephew PLC Hemostats & Sealants Description and Business Overview
6.11.3 Smith & Nephew PLC Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Smith & Nephew PLC Hemostats & Sealants Product Portfolio
6.11.5 Smith & Nephew PLC Recent Developments/Updates
6.12 CSL Behring
6.12.1 CSL Behring Corporation Information
6.12.2 CSL Behring Hemostats & Sealants Description and Business Overview
6.12.3 CSL Behring Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CSL Behring Hemostats & Sealants Product Portfolio
6.12.5 CSL Behring Recent Developments/Updates
6.13 Integra Lifesciences Corp
6.13.1 Integra Lifesciences Corp Corporation Information
6.13.2 Integra Lifesciences Corp Hemostats & Sealants Description and Business Overview
6.13.3 Integra Lifesciences Corp Hemostats & Sealants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Integra Lifesciences Corp Hemostats & Sealants Product Portfolio
6.13.5 Integra Lifesciences Corp Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostats & Sealants Industry Chain Analysis
7.2 Hemostats & Sealants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostats & Sealants Production Mode & Process
7.4 Hemostats & Sealants Sales and Marketing
7.4.1 Hemostats & Sealants Sales Channels
7.4.2 Hemostats & Sealants Distributors
7.5 Hemostats & Sealants Customers
8 Hemostats & Sealants Market Dynamics
8.1 Hemostats & Sealants Industry Trends
8.2 Hemostats & Sealants Market Drivers
8.3 Hemostats & Sealants Market Challenges
8.4 Hemostats & Sealants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
